April 14, 2021
AstraZeneca’s non-small cell lung cancer approved in China
AstraZeneca’s Tagrisso has been approved in China for the adjuvant treatment of patients with early-stage (IB, II and IIIA) epidermal growth factor…
Pharmaceuticals, Biotechnology and Life Sciences
Category: Asia
April 14, 2021
Sodium-bicarbonate can help reduce Covid symptoms, study shows
A certain peer-reviewed study (see more here) carried out at the Welcare Hospital, India, found out that kitchen staple, bicarbonate of soda is found to significantly reduce Covid-19 symptoms.
March 24, 2021
Bayer’s NTRK fusion-positive tumor drug approved in Japan
Bayer has announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has granted marketing authorization for larotrectinib, under the brand name Vitrakvi, for the treatment of Neurotrophic Tyrosine Receptor Kinase (NTRK) fusion-positive advanced or recurrent solid tumors.
February 15, 2021
Basilea divests its Chinese R&D subsidiary to PHT International
Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that it has entered into an agreement to divest its Chinese research and development (R&D) subsidiary Basilea Pharmaceutica China Ltd. (“BPC”), by selling BPC’s parent company BPh Investitionen Ltd. to the U.S.-based custom manufacturing organization PHT International Inc. (“PHT”).
January 25, 2021
Moderna’s vaccine coming to India
Reuters news agency referred to the Economic Times as saying Monday that Tata Group’s healthcare venture has reportedly started the first discussions with Moderna Inc for a partnership to launch its COVID-19 vaccine in India.
January 20, 2021
CPhI & P-MEC China gives a glimpse of the success returning pharma events will deliver in 2021
The recently hosted CPhI & P-MEC China 2020 – organized by Informa Markets and CCCMHPIE and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd. – attracted a remarkable 46,157 visits of professional pharma visitors, including 5,105 international attendees taking part online.
December 9, 2020
Takeda’s Pipeline Has Potential to Contribute Significantly to Revenue Growth Over Next Decade
Company Aiming for Mid-Single-Digit Revenue CAGR Over Next Decade Amounting to JPY5 Trillion ($47 Billion) by FY20301 Wave 1 Pipeline…
November 28, 2020
Dr. Reddy’s to Acquire Select Anti-Allergy Brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan
HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as…
July 6, 2020
Sinovac COVID-19 vaccine collaboration with Butantan approved by Brazilian regulator for Phase III Trial
Sinovac Biotech’s partnership with Butantan, a leading Brazilian producer of immunobiologic products and vaccines, has reached a milestone as it moved one step further to our commitment to developing vaccines for global use after getting the approval for Phase 3 trial from Brazilian National Regulatory Agency, Anvisa.
June 30, 2020
Sinovac ends Covid-19 affected first quarter 2020 with decerase in sales
Sinovac Biotech, a provider of biopharmaceutical producs in China, has reported sales for the first quarter of 2020 at $15.4 million, a decrease of 57.9% from $36.6 million in the prior year period, with a loss attributed to common shareholders of $7.4 million, in the same period.